Erectile Dysfunction Clinical Trial Landscape
Data updated: May 20, 2026
180 clinical trials tracked since 2008
Erectile Dysfunction is being studied across 180 clinical trials registered since 2008, with 34 programs currently active. The competitive pipeline includes 12 active Phase 3 trials, 16 active Phase 2 trials, and 8 active Phase 1 trials. Top industry sponsors include Aspargo Labs, Inc, EMS, Sanofi.
34 active
/
180 total (since 2008)
8
Phase 1 Active
60 total
16
Phase 2 Active
52 total
12
Phase 3 Active
53 total
3
Phase 4 Active
31 total
Top Industry Sponsors
Sorted by active Active Done Failed
Aspargo Labs, Inc 5 0 0
EMS 2 1 0
Sanofi 1 2 0
Biozeus Biopharmaceutical S.A. 1 1 0
Beijing Inno Medicine Co., Ltd. 1 0 0
+ 10 more sponsors — see full table below
Featured Phase 3 Trials
NCT07480161 RECRUITING
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Ankara City Hospital Bilkent n=90
NCT06489431 ACTIVE NOT RECRUITING
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
Rush University Medical Center n=200
NCT05232279 RECRUITING
Effect of Testofen on Erectile Function in an Adult Male Population
RDC Clinical Pty Ltd n=120
NCT05955001 RECRUITING
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
Mansoura University n=110
NCT06945315 RECRUITING
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Icahn School of Medicine at Mount Sinai n=196
+ 48 more Phase 3 trials — see full database below
Erectile Dysfunction — Trials Started by Year (last 10 years)
2016 4
2017 4
2018 4
2019 8
2020 5
2021 7
2022 10
2023 9
2024 11
2025 9
2026 11
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
Aspargo Labs, Inc 5
EMS 3
Sanofi 3
Biozeus Biopharmaceutical S.A. 2
Beijing Inno Medicine Co., Ltd. 1
RDC Clinical Pty Ltd 1
Seattle Gummy Company 1
R3 Stem Cell 1
VIVUS LLC 14
Eli Lilly 12
Active Trials by Phase
Phase 1 8
Phase 2 16
Phase 3 12
Phase 4 3
Enrollment Size Distribution
1-50 74
51-200 56
201-500 25
501-1k 11
1k+ 4
All Industry Sponsors
Sorted by active Active Done Failed
Aspargo Labs, Inc 5 0 0
EMS 2 1 0
Sanofi 1 2 0
Biozeus Biopharmaceutical S.A. 1 1 0
Beijing Inno Medicine Co., Ltd. 1 0 0
RDC Clinical Pty Ltd 1 0 0
Seattle Gummy Company 1 0 0
R3 Stem Cell 1 0 0
VIVUS LLC 0 14 0
Eli Lilly 0 12 0
Vigonvita Life Sciences 0 10 0
Bayer 0 6 0
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 0 5 0
Hanmi Pharmaceutical Company Limited 0 5 0
Warner Chilcott 0 4 1
NCT07480161 RECRUITING
Mesenchymal Stem Cell and Exosome Therapy for Diabetic Erectile Dysfunction
Ankara City Hospital Bilkent n=90
NCT06489431 ACTIVE NOT RECRUITING
Irrisept vs Traditional Antibiotic Irrigation for Virgin Penile Prosthesis Placement
Rush University Medical Center n=200
NCT07177326 NOT YET RECRUITING
Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study
Assiut University n=142
NCT05232279 RECRUITING
Effect of Testofen on Erectile Function in an Adult Male Population
RDC Clinical Pty Ltd n=120
NCT05955001 RECRUITING
Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate
Mansoura University n=110
NCT06945315 RECRUITING
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
Icahn School of Medicine at Mount Sinai n=196
NCT06942988 ACTIVE NOT RECRUITING
Efficacy of Intracavernous Platelet-rich Plasma Injection in the Treatment of Erectile Dysfunction
Bakirkoy Dr. Sadi Konuk Research and Training Hospital n=34
NCT06583590 RECRUITING
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
Aswan University Hospital n=32
NCT06520839 RECRUITING
Genetic Factors of Erectile Dysfunction Degree and Response to Tadalafil Treatment in Patients With Diabetes
University Medical Centre Ljubljana n=90
NCT06264414 NOT YET RECRUITING
Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
EMS n=262
NCT05052879 NOT YET RECRUITING
Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation
EMS n=232
NCT04185441 COMPLETED
Efficacy and Safety of Tanzânia Association in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
EMS n=295
NCT05490680 COMPLETED
A New Sildenafil Oral Film in Patients With Erectile Dysfunction
IBSA Institut Biochimique SA n=488
NCT06301854 COMPLETED
Long-term Safety of TPN171H Tablet in Erectile Dysfunction.
Vigonvita Life Sciences n=472
NCT03917459 COMPLETED
COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure
Novartis Pharmaceuticals n=27
NCT04984993 COMPLETED
Clinical Investigation Using MED3000 Gel or Tadalafil Tablets in the Treatment of Erectile Dysfunction
Futura Medical Developments Ltd. n=116
NCT04357353 TERMINATED
The Role of Platelet Rich Plasma for Erectile Dysfunction
University of Nebraska n=13
NCT05363644 WITHDRAWN
BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy
AdventHealth
NCT05188989 COMPLETED
Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.
Vigonvita Life Sciences n=765
NCT03813992 COMPLETED
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
Futura Medical Developments Ltd. n=1,005
NCT04050020 COMPLETED
Platelet-rich Plasma (PRP) Injection for Treatment of Erectile Function
Institute for the Study of Urological Diseases, Greece n=60
NCT02798159 COMPLETED
Safety and Efficacy of TD0025 (Rocket1h) for Treatment of Erectile Dysfunction
Vietstar Biomedical Research n=168
NCT00893113 COMPLETED
An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms
Chesapeake Urology Research Associates n=74
NCT01937871 COMPLETED
A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)
Eli Lilly and Company n=909
NCT01705197 COMPLETED
This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.
JW Pharmaceutical n=195
NCT02587988 COMPLETED
Trial to Evaluate the Efficacy and Safety of HCP1302
Hanmi Pharmaceutical Company Limited n=232
NCT02850718 COMPLETED
A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
iX Biopharma Ltd. n=48
NCT01065012 COMPLETED
Treatment of Erectile Dysfunction - Long Term Safety and Efficacy
Warner Chilcott n=1,027
NCT02068417 TERMINATED
Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)
Storz Medical AG n=40
NCT00655629 COMPLETED
Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.
Bayer n=339
NCT01901640 COMPLETED
Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction
Dong-A Pharmaceutical Co., Ltd. n=302
NCT01067261 COMPLETED
Transcutaneous Mechanical Nerve Stimulation (TMNS) by Vibration in the Preservation and Restoration of Urinary Continence and Erectile Function and in the Treatment of Erectile Dysfunction and Urinary Incontinence in Conjunction With Nerve Sparing Radical Prostatectomy
Copenhagen University Hospital at Herlev n=68
NCT01774864 COMPLETED
Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction
Dong-A Pharmaceutical Co., Ltd. n=349
NCT01063855 COMPLETED
Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. n=495
NCT01272297 COMPLETED
The Effect of Low Intensity Shock Wave Therapy for ED in PDE5i Non Responders
Rambam Health Care Campus n=29
NCT00895011 COMPLETED
Research Evaluating an Investigational Medication for Erectile Dysfunction - Post-Prostatectomy
VIVUS LLC n=298
NCT00809471 COMPLETED
Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D)
VIVUS LLC n=390
NCT00853606 COMPLETED
Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction
VIVUS LLC n=712
NCT00790751 COMPLETED
Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED
VIVUS LLC n=646
NCT01305083 COMPLETED
Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.
Abdi Ibrahim Ilac San. ve Tic A.S. n=118
NCT01274949 COMPLETED
The Effect of Low Intensity Shockwave Therapy for ED in Post Radical Prostatectomy Patients Who Didn't Respond to PDE5i
Rambam Health Care Campus n=20
NCT00855582 COMPLETED
A Study in the Treatment of Erectile Dysfunction and Benign Prostate Hyperplasia
Eli Lilly and Company n=606
NCT01274156 COMPLETED
Double Blind Placebo Controlled Study on the Effect of Extracorporal Shock Wave Therapy on Erectile Dysfunction
Rambam Health Care Campus n=60
NCT00836693 COMPLETED
Effect of Tadalafil Once a Day in Men With Erectile Dysfunction
Eli Lilly and Company n=217
NCT00734604 COMPLETED
A Study for Patients With Erectile Dysfunction to Test Whether Tadalafil Taken Once a Day Can Better Improve Psychological Outcomes.
Eli Lilly and Company n=378
NCT00903981 COMPLETED
Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
JW Pharmaceutical n=208
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only